Todd Shegog

Officer, SYNLOGIC, INC.

Companies

Cogent Biosciences, Inc.Board member Feb 24, 2021 to now¹
Forma Therapeutics Holdings, Inc.Chief financial officer Jun 18, 2020 to Oct 14, 2022²
SYNLOGIC, INC.Officer Aug 30, 2017 to Mar 6, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Forma Therapeutics Holdings, Inc.0 shares⁴Oct 14, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 14, 2022U 56,143 shares of Forma Therapeutics Holdings, Inc.⁴
Feb 28, 2022Granted 33,330 shares of Forma Therapeutics Holdings, Inc.⁵
Feb 23, 2022Sold 5,687 shares at $9.78 of Forma Therapeutics Holdings, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCogent Biosciences, Inc., Board member
2
SEC EDGARForma Therapeutics Holdings, Inc., Chief financial officer
3
SEC EDGARSYNLOGIC, INC., Officer
4
SEC EDGARForma Therapeutics Holdings, Inc. shares after the filing of Oct 14, 2022
5
SEC EDGARForm 4 filed Mar 2, 2022
6
SEC EDGARForm 4 filed Feb 25, 2022